EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

A CASE SERIES OF COVID-19 PATIENTS WITH MUCORMYCOSIS INFECTION-LESSONS LEARNED FROM SECOND WAVE

Anita Basavaraj, Bilia K. Aipu* and Dharshan P.

ABSTRACT

Background: The outbreak of coronavirus has spread rapidly on a global scale. Secondary infections especially mucormycosis cases have increased prevalence in covid 19 patients. Aim: We aimed to describe a case series of covid 19 patients with mucormycosis infection. Materials & Methods: 10 cases who were admitted and treated in our covid 19 hospital in the month of April-May 2021 were studied. Demographic information, clinical features, and treatment data were extracted from medical records. Observations & Results: Among the 10 patients,6 were males and 4 were females. The patients were aged from 35 years to 80 years. All patients were diabetic. Among these 4 out of 10 had received corticosteroid treatment.9 of the patients had presented with orbital cellulitis and 1 with facial puffiness. During the hospital stay, 5 developed cerebrovascular accident. Radiological study of all had shown sinusitis.6 of these patients underwent mortality mainly due to cerebral extension.

Keywords: Mucormycosis, Covid 19, Diabetes mellitus.

[Full Text Article] [Download Certificate]